---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-061237"
form_type: "8-K"
ticker: "HRMY"
cik: "0001802665"
company_name: "Harmony Biosciences Holdings, Inc."
filed_at: "2026-05-14T20:31:08+00:00"
generated_at: "2026-05-14T20:32:59.802209+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Harmony Biosciences shareholders elect four directors, ratify auditor, approve say-on-pay at 2026 annual meeting

## Summary
- All four Class III director nominees elected: Geno Germano (44.96M for), Troy Ignelzi (32.81M), Ron Philip (31.83M), Andreas Wicki (25.11M).
- Deloitte & Touche ratified as independent auditor for FY2026 with 49.39M for, 0.83M against, 0.17M abstain.
- Say-on-pay advisory vote approved: 33.25M for, 13.04M against, 0.19M abstain; broker non-votes of 3.89M.
- Quorum of 50.38M shares represented out of outstanding; all proposals passed.

## SEC filing metadata
- accession: 0001104659-26-061237
- form_type: 8-K
- ticker: HRMY
- cik: 0001802665
- company_name: Harmony Biosciences Holdings, Inc.
- filed_at: 2026-05-14T20:31:08+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802665/000110465926061237/0001104659-26-061237-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802665/000110465926061237/hrmy-20260514x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-061237
- JSON: https://secwatch.observer/filing/0001104659-26-061237.json
- Plain text: https://secwatch.observer/filing/0001104659-26-061237.txt

## Key facts
- Shareholder Votes
  Harmony Biosciences Holdings, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-05-14
  source text: Proposal 2. The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1802665/000110465926061237/0001104659-26-061237-index.htm
- Shareholder Votes
  Harmony Biosciences Holdings, Inc. shareholders approved Election of four Class III directors at the 2026-05-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-05-14
  source text: Proposal 1. The election of four Class III directors listed below to serve until the Company’s 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1802665/000110465926061237/0001104659-26-061237-index.htm
- Shareholder Votes
  Harmony Biosciences Holdings, Inc. shareholders approved Approval on a non-binding, advisory basis, of the compensation of the Company’s named executive officers at the 2026-05-14 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-05-14
  source text: Proposal 3. The approval on a non-binding, advisory basis, of the compensation of the Company’s named executive officers pursuant to the SEC’s compensation disclosure rules.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1802665/000110465926061237/0001104659-26-061237-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.